Literature DB >> 22475655

[Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations].

Claudia Colomba1, Francesco Lalicata, Lucia Siracusa, Laura Saporito, Danilo Di Bona, Giovanni Giammanco, Simona De Grazia, Lucina Titone.   

Abstract

Cytomegalovirus primary infection is considered dangerous for some kinds of patients: immunocompromised (HIV-infected and transplanted patients), newborns with congenital infection, and immunocompetent patients in critical condition. CMV infection is usually asymptomatic or only mildly symptomatic in immunocompetent hosts. We collected all cases of acute CMV infection that came to our attention during the period November 2009 - May 2011 to analyze their clinical features. Immunoenzymatic methods (ELISA) were used for the detection of specific IgM and IgG antibodies in every case. We observed 73 cases of acute CMV infection. The male-female ratio was 1.5/1. The average age was 36.4. All the patients had fever, 16 (22%) pharyngitis, only 9 (12.3%) lymphadenopathy. The most common complications were hepatitis, encephalitis, pericarditis and pneumonia. Unknown genetic factors may greatly influence the clinical expression of the illness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475655

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  3 in total

1.  CMV infection, TLR-2 and -4 expression, and cytokine profiles in early-onset preeclampsia with HELLP syndrome.

Authors:  Fang Xie; Peter von Dadelszen; Joseph Nadeau
Journal:  Am J Reprod Immunol       Date:  2014-04       Impact factor: 3.886

2.  Cytomegalovirus-Induced Pericarditis, Pulmonary Embolism, and Transaminitis in an Immunocompetent Patient.

Authors:  Waiz Wasey; Navpreet Badesha; Maria Rossi; Caitlin Carter; Samantha Bibee
Journal:  Cureus       Date:  2021-11-05

3.  Cytomegalovirus encephalitis in an immunocompetent child: a sceptic diagnosis.

Authors:  Filipa Belo; Isabel Mendes; Manuela Calha; Carla Mendonça
Journal:  BMJ Case Rep       Date:  2012-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.